期刊文献+

胆固醇24S-羟化酶和三磷酸腺苷结合盒转运子A1基因多态性与阿尔茨海默病的相关性分析 被引量:3

Correlation of cholesterol 24-hydroxylase and ATP-binding cassette transporter AI polymorphisms with Alzheimer's disease
原文传递
导出
摘要 目的探讨胆固醇24S-羟化酶(CYP46)基因第二内含子 A→G多态性位点和三磷酸腺苷结合盒转运子 A1(ABCA1)基因第六外显子 G→A(R219K)多态性位点与散发性阿尔茨海默病(SAD)易感性的关系。方法采用病例-对照研究方法,利用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)技术对168例 SAD 患者和215名正常对照的 CYP46和 ABCA1基因多态性进行检测,比较不同基因型与阿尔茨海默病(AD)发病风险之间的关系。结果 CYP46基因第二内含子 A→G多态性等位基因频率和基因型分布在 SAD 组和正常对照组差异无统计学意义。ABCA1基因第六外显子 G→A多态性的基因型分布在两组之间差异有统计学意义(x^2=8.230,P=0.016),AD 组携带 A等位基因(G/A+A/A 基因型)的频率明显低于对照组(61.3%vs 73.5%,x^2=6.444,P=0.011)。Logistic 回归分析表明携带 A 等位基因者(G/A+A/A 基因型)比携带 GG 基因型者 AD 发病风险低43%(校正后 OR=0.57,95%CI=0.36~0.91,P=0.019),而 AA 纯合子比携带 GG 基因型者 AD 发病风险低60%(校正后 OR=0.40,95%CI=0.21~0.77,P=0.006)。结论 CYP46第二内含子 A→G多态性可能与 AD 发病无关;而 ABCA1基因第六外显子 G→A多态性与 SAD 相关,携带 A 等位基因或 AA 基因型对 SAD 发病可能有一定的保护作用。 Objective To investigate the association of the single nucleotide polymorphisms (SNPs) A→G in the intron 2 of cholesterol 24-hydroxylase (CYP46) gene and C→A (R219K) in the exon 6 of ATP-hinding cassette transporter A1 (ABCA1) gene with sporadic Alzheimer's disease (SAD) in the Han Chinese population. Methods Peripheral blood samples were collected from 168 SAD patients, 74 males and 94 females, aged 74 ± 8 (52 - 95 ), with an average age at onset of 69 ±7 (47 - 86 ), and sex-, and age-matched 215 healthy persons. PCR-restriction fragment length polymorphism (PCR-RFLP) was used to detect the genotypos. Apolipoprotein E (ApoE) genotyping was conducted. The strength of association between the polymorphisms and AD was estimate. Results The frequency of ApoE genotype of the SAD patients was 14%, significantly higher than that of the controls (5.1%, X^2 =19.060, P〈0.01). The risk of SAD in those with at least one ε4 allele was 2.8 times that in those without e 4 allele ( OR = 2. 82, 95% CI = 1.54-5. 17, P = 0. 001 ). There was no significant difference in the genotype or allele frequencies for CYP46 gene between the SAD patients and controls. However, there was an obvious association between the polymorphism of ABCA1 gene and SAD ( X^2 = 8.230, P = 0.016). The frequency of G/A + A/A genotypes in the SAD patients was 61. 3%, significantly lower than that of the controls (73.5%, X^2 = 6. 444, P = 0.011 ). The risk of SAD in the carriers of A alleles ( G/A + A/A genotypes) was significantly lower than those with GG genotype by 43% (adjusted OR =0.57, 95% CI =0. 36-0. 91, P=0.019), and the risk of SAD in the AA homozygote carriers was significantly lower than that of the GG genotypecarriers by60% (adjusted OR=0.40; 95% C1=0.21-0.77, P=0.006). Conclusion The CYP46 intron 2 polymorphism may not be associated with the risk of AD, but AA genotype or A allele of ABCAI gene may have a protective effect for AD in Hart Chinese.
作者 王芬 贾建平
出处 《中华医学杂志》 CAS CSCD 北大核心 2007年第9期614-618,共5页 National Medical Journal of China
关键词 阿尔茨海默病 甾类-羟化酶类 三磷酸腺苷结合盒转运子 多态性 单核苷酸 Alzheimer disease Sleroid-hydroxylases ATP-hinding cassette transporters Polymorphism, single lmcieotide
  • 相关文献

参考文献19

  • 1Simons M, Keller P, Dichgans J, et al. Cholesterol and Alzhermer's disease. Is there a link? Neurology, 2001,57, 1089-1093.
  • 2Lurid EG, Guileyardo JM, Russell DW. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc Natl Acad Sci USA, 1999, 96: 7238-7243.
  • 3Wang N, Tall AR. Regulation and mechanisms of ATP-binding cassette transporter Al-mediated cellular cholesterol efflux.Arterioscler Thromb Vasc Biol, 2003, 23: 1178-1184.
  • 4Kolsch H, Lutjohann D, Ludwig M, et al. Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease. Mol Psychiatry, 2002, 7: 899-902.
  • 5Papassotiropoulos A, Streffer JR, Tsolaki M, et al. Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. Arch Neurol, 2003, 60: 29-35.
  • 6Sundar PD, Feingold E, Minster RL, et al. Gender-specific association of ATP-binding cassette transporter 1 (ABCA1)polymorphisms with the risk of late-onset Alzheimer's disease.Neurobiol Aging, 2006 May 22, [Epub ahead of print].
  • 7Katzov H, Chalmers K, Palmgren J, et al. Genetic variants of ABCAl modify Alzheimer disease risk and quanlitatlve traits related to β-amyloid metabolism. Hum Murat, 2004, 23: 358-367.
  • 8Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res, 1990, 31 : 545-548.
  • 9何小明,张振馨,张俊武,周涌涛,唐牟尼,武成斌,洪震.胆固醇24S-羟化酶基因多态性与阿尔茨海默病的相关性分析[J].中华神经科杂志,2006,39(1):44-47. 被引量:8
  • 10Borroni B, Archetti S, Agosti C, et al. Intronic CYP46 polymorphism along with APOE genotype in sporadic Alzheimer disease: from risk factors to disease modulators. Neurobiol Aging,2004, 25: 747-751.

二级参考文献24

  • 1Fassbender K, Simons M, Bergmann C, et al. Simvastatin strongly reduces Alzheimer' s disease A1542 and AβIO levels in vitro and in vivo. Proc Natl Acad Sci U S A, 2001,98:5856-5861.
  • 2Papassotiropeulos A, Lutjohann D, Bagli M, et al. Plasma 24Shydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer' s disease. Neuroreport,2000, 11:1959-1962.
  • 3Papassotiropoulos A, Streffer JR, Tsolaki M, et al. Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. Arch Neurol,2003, 60:29-35.
  • 4Wang B, Zhang C, Zheng W, et al. Association between a T/C polymorphism in intron 2 of cholesterol 24S-hydroxylase gene and Alzheimer's disease in Chinese. Neurosci Lett 2004, 369: 104-107.
  • 5Borroni B, Archetti S, Agosfi C, et aL Intronic CYP46 polymorphism along with APOE genotype in sporadic Alzheimer disease: from risk factors to disease modulators. Neumbiol Aging,2004, 25 : 747-751.
  • 6Combarros O, lnfante J, Llorca J, et al. Genetic association of CYP46 and risk for Alzheimer's disease. Dementia Geriatr Cogn Disord, 2004, 18: 257-260.
  • 7Desai P, DeKosky ST, Kamboh MI, et al. Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer' s disease. Neurosci Lett, 2002, 328:9-12.
  • 8Chalmers KA, Culpan D, Kehoe PG, et al. APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer' s disease.Neuroreport, 2004, 15: 95-98.
  • 9Kolsch H, Lutjohann D, Ludwig M, et al. Polymorphism in the cholesterol 24S-hydroxylase geue is associated with Alzheimer's disease. Mol Psychiatry, 2002, 7 : 899-902.
  • 10Ingelsson M, Jesneck J, Irizarry MC, et al. Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer' s disease. Neurosci Lett 2004, 367:228-231.

共引文献28

同被引文献9

  • 1何小明,张振馨,张俊武,周涌涛,唐牟尼,武成斌,洪震.胆固醇24S-羟化酶基因多态性与阿尔茨海默病的相关性分析[J].中华神经科杂志,2006,39(1):44-47. 被引量:8
  • 2唐雷,吕泽平,杨泽,胡才友,梁积英,郑陈光,王彬彬,史晓红,孙飞,韦勇,江文宇,梁庆华,黎华,金锋,王沥.胆固醇24S-羟化酶基因与晚发性阿尔茨海默病的关联[J].中华老年医学杂志,2007,26(1):13-15. 被引量:5
  • 3Wang B,Zhang C,Zheng W,et al.Association between a T/C polymorphism in intron 2 of cholesterol 24S-hydroxylase gene and Alzheimer' s disease in Chinese.Neurosci Lett,2004,369:104-107.
  • 4Borroni B,Archetti S,Agosti C,et al.Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer disease,from risk factors to disease modulators.Neurobiol Aging,2004,25,747-751.
  • 5Combarros O,Infante J,Llorca J,et al.Genetic Association of CYP46 and risk for Alzheimer' s disease.Dement Geriatr Cogn Disord,2004,18:257-260.
  • 6Russell DW,Halford RW,Ramirez DM,et al.Cholesterol 24-hydroxylase:an enzyme of cholesterol turnover in the brain.Annu Rev Biochem,2009,78,1017-1040.
  • 7Helisalmi S,Vepsalainen S,Koivisto AM,et al.Association of CYP46 intron 2 polymorphism in Finnish Alzheimer's disease samples and a global scale summary.J Neurol Neurosurg Psychiatry,2006,77:421-422.
  • 8Kolsch H,Lutjohann D,Jessen F,et al.CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism.Eur Psychiatry,2009,24:183-190.
  • 9汤哲,孟琛,陈彪.北京地区老年痴呆流行病学研究[J].中华流行病学杂志,2003,24(8):734-736. 被引量:68

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部